161 related articles for article (PubMed ID: 29988516)
21. Design of Catalase Monolithic Tablets for Intestinal Targeted Delivery.
Alothman M; Ispas-Szabo P; Mateescu MA
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33430270
[TBL] [Abstract][Full Text] [Related]
22. The presence of propylene glycol alginate increased the stability and intestine-targeted delivery potential of carboxymethyl starch-stabilized emulsions.
Wang L; Wei Z; Xue C
Food Res Int; 2022 Jul; 157():111387. PubMed ID: 35761643
[TBL] [Abstract][Full Text] [Related]
23. Stabilization of starch-based microgel-lysozyme complexes using a layer-by-layer assembly technique.
Zhang B; Pan Y; Chen H; Liu T; Tao H; Tian Y
Food Chem; 2017 Jan; 214():213-217. PubMed ID: 27507468
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.
Amrutkar JR; Gattani SG
AAPS PharmSciTech; 2009; 10(2):670-7. PubMed ID: 19459052
[TBL] [Abstract][Full Text] [Related]
25. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
[TBL] [Abstract][Full Text] [Related]
26. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
27. Self-assembled polyelectrolyte complexes films as efficient compression coating layers for controlled-releasing tablets.
Li W; Huo M; Sen Chaudhuri A; Yang C; Cao D; Wu Z; Qi X
J Mater Sci Mater Med; 2017 May; 28(5):67. PubMed ID: 28337667
[TBL] [Abstract][Full Text] [Related]
28. N-acylated chitosan: hydrophobic matrices for controlled drug release.
Le Tien C; Lacroix M; Ispas-Szabo P; Mateescu MA
J Control Release; 2003 Nov; 93(1):1-13. PubMed ID: 14602417
[TBL] [Abstract][Full Text] [Related]
29. Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch.
Lemieux M; Gosselin P; Mateescu MA
AAPS PharmSciTech; 2010 Jun; 11(2):775-85. PubMed ID: 20443088
[TBL] [Abstract][Full Text] [Related]
30. Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings.
Mulhbacher J; Ispas-Szabo P; Lenaerts V; Mateescu MA
J Control Release; 2001 Sep; 76(1-2):51-8. PubMed ID: 11532312
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon-specific drug delivery systems.
Aiedeh K; Taha MO
Arch Pharm (Weinheim); 1999 Mar; 332(3):103-7. PubMed ID: 10228455
[TBL] [Abstract][Full Text] [Related]
32. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
33. Chitosan based in situ forming polyelectrolyte complexes: A potential sustained drug delivery polymeric carrier for high dose drugs.
Lal N; Dubey J; Gaur P; Verma N; Verma A
Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():491-498. PubMed ID: 28629045
[TBL] [Abstract][Full Text] [Related]
34. Carboxymethyl starch-chitosan-coated iron oxide magnetic nanoparticles for controlled delivery of isoniazid.
Saikia C; Hussain A; Ramteke A; Sharma HK; Maji TK
J Microencapsul; 2015; 32(1):29-39. PubMed ID: 25090597
[TBL] [Abstract][Full Text] [Related]
35. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
36. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system.
Xu Y; Zhan C; Fan L; Wang L; Zheng H
Int J Pharm; 2007 May; 336(2):329-37. PubMed ID: 17223290
[TBL] [Abstract][Full Text] [Related]
37. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
Nabais T; Zaraa S; Leclair G
Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
[TBL] [Abstract][Full Text] [Related]
38. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting.
Drechsler M; Garbacz G; Thomann R; Schubert R
Eur J Pharm Biopharm; 2014 Nov; 88(3):807-15. PubMed ID: 25301294
[TBL] [Abstract][Full Text] [Related]
40. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations.
Calinescu C; Mulhbacher J; Nadeau E; Fairbrother JM; Mateescu MA
Eur J Pharm Biopharm; 2005 May; 60(1):53-60. PubMed ID: 15848056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
